4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: April 13, 2022
Period of Report: April 11, 2022
Accession Number: 0001104659-22-045488

View Document ↗ View on SEC.gov ↗